Arizona Bioscience News: COVID-19 in Arizona; Amblyotech acquired by Novartis; Bio data subject of KJZZ interview

April 23, 2020

By Matt Ellsworth

As Arizona allows more broad testing for COVID-19, TGen researchers are mapping the DNA of patients who have tested positive for clues about genetic links to the disease. Arizona State University’s Luminosity Lab is connecting Banner Health, Dignity Health and other providers with volunteers who make personal protective equipment, while the University of Arizona will create 250,000 antibody tests to distribute to first responders and health care workers. And STEM students are doing their part to help those on the front lines.

COVID-19 testing now allowed more broadly, state health department says / Arizona Republic

Are some people more likely to get sick with COVID-19? Genetics may offer clues / Arizona Republic

Experts detail what it will take to reopen Arizona / ABC 15

ASU network connects health care providers to volunteers making protective gear / KJZZ

ASU crowdsources PPE for health care workers / 12 News

UA president discusses antibody testing, financial impact of pandemic / Arizona Public Media

Models predicting the arc of the coronavirus pandemic make vastly different projections for Arizona / Arizona Republic

New UA research project uses texts to collect COVID-19 data across Arizona / Arizona Daily Star

Arizona researchers intend to play key roles in defeating COVID-19 / Cronkite News

Arizona genomics researchers unite to crack the coronavirus / KJZZ

Accelerate Diagnostics latest publicly traded Arizona company to get PPP loan / Phoenix Business Journal

NAU labs work to support medical facilities amid COVID-19 crisis / Arizona Daily Sun

Ambition and a class project are helping thousands of Arizona medical workers on the front lines of the fight against COVID-19 / 12 News

Tucsonans hear Banner Health’s call for homemade masks / Arizona Public Media

How Arizona sewing enthusiasts are helping solve the face mask shortage / Arizona Republic

Arizona makes progress in biosciences sector / KJZZ

Mitch Horowitz, principal and managing director of TEConomy Partners, talks with The Show about new bioscience performance data and whether COVID-19-related research could impact Arizona’s biosciences sector even further.

Pharma giant acquires Phoenix-based startup developing eye treatments / Phoenix Business Journal

Phoenix-based digital therapeutics company Amblyotech, which has been developing treatments for lazy eye and other ocular disorders, has announced its acquisition by New Jersey pharmaceutical giant Novartis.

Major lease renewed at Park Central amid flurry of activity at Phoenix project / Phoenix Business Journal

District Medical Group’s Children’s Rehabilitative Services, which has been a tenant at Park Central Mall in midtown Phoenix since 2013, has renewed a lease on its 56,000-square-foot space for another 10 years.

Sign up to receive Arizona Bioscience News weekly